Improve quality of life and prevent ischemic tissue injury
Patient education on trigger avoidance
Severe cases/Ischemia
Pharmacologic
Oral vasodilators
Nifedipine 30 to 180 mg/day
Amlodipine 5 to 20 mg/day
Topical nitrates
Phosphodiesterase 5 inhibitors
Surgical sympathetic blockade
Pharmacologic
Oral vasodilators
Nifedipine 30 to 180 mg/day
Amlodipine 5 to 20 mg/day
Topical nitrates
Phosphodiesterase 5 inhibitors
Surgical sympathetic blockade
Oral vasodilators
Nifedipine 30 to 180 mg/day
Amlodipine 5 to 20 mg/day
Topical nitrates
Phosphodiesterase 5 inhibitors
Nifedipine 30 to 180 mg/day
Amlodipine 5 to 20 mg/day
Raynaud’s disease
Primary 
Peripheral artery disease
Symptoms without an associated disorder
Polyarteritis nodosa
Secondary 
Takayasu arteritis
Popliteal cyst